Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 975 of 976 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 11/03/17
End: 12/04/17
Due: 12/04/18
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 06/12/19
End: 04/03/20
Due: 04/03/21
Phase: N/A
Priority: Normal
Start: 02/09/21
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/01/20
End: 02/24/21
Due: 02/24/22
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 01/10/18
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 11/30/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/12/21
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 01/01/22
Due: 01/01/23
Phase: N/A
Priority: Normal
Start: 06/14/24
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 01/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/06/22
End: 12/31/25
Due: 12/31/26
Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 12/31/22
Due: 12/31/23